| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 71.633 | 87.217 | 32.377 | 56.379 |
| Total Income - EUR | - | - | - | 1.042 | 11.108 | 982 | 71.636 | 87.218 | 32.377 | 56.379 |
| Total Expenses - EUR | - | - | - | 7.947 | 11.169 | 77 | 97.895 | 88.010 | 28.945 | 55.835 |
| Gross Profit/Loss - EUR | - | - | - | -6.905 | -60 | 905 | -26.259 | -793 | 3.432 | 544 |
| Net Profit/Loss - EUR | - | - | - | -6.907 | -60 | 905 | -26.259 | -3.409 | 2.857 | 456 |
| Employees | - | - | - | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Samigel Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 5.007 | 4.910 | 4.817 | 4.710 | 4.725 | 4.710 | 4.684 |
| Current Assets | - | - | - | 1.622 | 17 | 35 | 86.115 | 39.902 | 33.316 | 100.924 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 693 |
| Receivables | - | - | - | 0 | 0 | 0 | 85.406 | 39.812 | 33.321 | 100.225 |
| Cash | - | - | - | 1.622 | 17 | 35 | 710 | 90 | -5 | 6 |
| Shareholders Funds | - | - | - | -1.857 | -1.881 | -940 | -27.179 | -32.828 | -29.871 | -29.248 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 8.485 | 6.809 | 5.793 | 118.004 | 77.454 | 67.898 | 134.857 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Samigel Bio S.r.l.